Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma |
Asthma | Phase 2 | Spain Hungary South Africa Guatemala Colombia Poland United Kingdom Bulgaria View All |
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® |
Asthma | Korea, Republic of | |
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. |
Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic | Phase 2 | United States Greece Spain China Italy Malaysia View All |
Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia |
Hypercholesterolemia | Phase 4 | Germany |
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma |
Multiple Myeloma | Phase 2 | Brazil |
Roll-over Study to Allow Continued Access to Ribociclib |
Metastatic Breast Cancer | Phase 4 | United States South Africa Turkey Brazil Poland Vietnam Hong Kong Italy Costa Rica Argentina Taiwan View All |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase 3 | United States Puerto Rico Spain India Greece Slovakia China Poland South Africa Argentina Portugal Brazil Romania Italy Canada Turkey France United Kingdom Slovenia Japan Mexico Bulgaria Croatia Sweden Estonia View All |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase 3 | United States United Arab Emirates Spain Jordan Belgium Israel Lebanon China Switzerland Colombia Slovakia Argentina Poland India Ireland Austria Guatemala Saudi Arabia Taiwan Lithuania Malaysia Italy Croatia Bulgaria Latvia Netherlands Chile Hong Kong Denmark Georgia United Kingdom View All |
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab |
Extensive Stage Small Cell Lung Cancer | Phase 1, Phase 2 | United States Spain Germany United Kingdom France View All |
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer |
Non-Small Cell Lung Cancer | Phase 3 | United States Denmark Turkey Romania Spain Jordan Lebanon Greece Australia Italy India Thailand China Serbia Hungary Argentina Korea, Republic of Mexico Norway Slovenia Vietnam Hong Kong Brazil Malaysia Canada Portugal Colombia Czech Republic Bulgaria Iceland Poland Chile United Kingdom Taiwan Estonia Finland Croatia View All |